FEURX | RYMPX | FEURX / RYMPX | |
Total Expense Ratio | 0.83 | 1.55 | 54% |
Annual Report Gross Expense Ratio | 0.83 | 1.58 | 53% |
Fund Existence | 8 years | 22 years | - |
Gain YTD | 53.217 | 52.834 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.8B | 117M | 3,245% |
Annual Yield % from dividends | 3.76 | 0.00 | - |
Returns for 1 year | 62.86 | 55.44 | 113% |
Returns for 3 years | 88.52 | 62.38 | 142% |
Returns for 5 years | 85.98 | 54.53 | 158% |
Returns for 10 years | N/A | 140.37 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFAX | 12.20 | -0.07 | -0.57% |
AlphaCentric Life Sciences & Hlthcare A | |||
LMPIX | 36.18 | -0.37 | -1.01% |
ClearBridge Appreciation FI | |||
TNBAX | 19.54 | -0.22 | -1.09% |
1290 SmartBeta Equity A | |||
VCGAX | 32.66 | -0.43 | -1.30% |
VALIC Company I Systematic Core Fund | |||
JMVCX | 15.02 | -0.20 | -1.31% |
Janus Henderson Mid Cap Value C |